Current Liabilities Cambio Fecha
AbbVie USD 34.77B 2.53B 2023-09
Amarin USD 266.69M 4.24M 2023-09
ANI Pharmaceuticals USD 145.48M 11.12M 2023-12
Bristol-Myers Squibb USD 23.46B 3.31B 2023-09
Eli Lilly USD 22B 3.08B 2023-09
Heron Therapeutics USD 79.74M 6.98M 2023-09
Hikma Pharmaceutical USD 1.22B 138M 2023-06
Ligand Pharmaceuticals USD 16.78M 1.06M 2023-12
Merck USD 23.09B 300M 2023-09
Pacira USD 97.38M 3.72M 2023-12
Patterson Companies USD 1.28B 135.17M 2023-12
Perrigo USD 1.01B 48.5M 2023-09
Pfizer USD 31.14B 3.51B 2023-09
Phibro Animal Health USD 172.36M 3.64M 2023-09
Revance Therapeutics USD 82.16M 8.08M 2023-09
Supernus Pharmaceuticals USD 290.2M 2.66M 2023-12
Takeda JPY 2.37T 134.12B 2023-09
Teva Pharmaceutical Industries USD 11.39B 449M 2023-09
Xeris Pharmaceuticals USD 87.04M 7.36M 2023-09
Zoetis USD 1.89B 281M 2023-12



Endo International Pasivo Circulante - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Mar 2024.